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Abstract 
Background: Changes in electroencephalography (EEG) voltage range are used to monitor 
the depth of anaesthesia, as well as predict outcome after hypoxia-ischaemia in neonates. 
Xenon is being investigated as a potential neuroprotectant after hypoxic-ischaemic brain 
injury, but the effect of Xenon on EEG parameters in children or neonates is not known. This 
study aimed to examine the effect of 50% inhaled Xenon on background amplitude-
integrated EEG (aEEG) activity in sedated healthy newborn pigs. 
Methods: Five healthy newborn pigs, receiving intravenous fentanyl sedation, were 
ventilated for 24h with 50%Xenon, 30%O2 and 20%N2 at normothermia. The upper and lower 
voltage-range of the aEEG was continuously monitored together with cardiovascular 
parameters throughout a 1h baseline period with fentanyl sedation only, followed by 24h of 
Xenon administration. 
Results: The median (IQR) upper and lower aEEG voltage during 1h baseline was 48,0µV 
(46,0 – 50,0) and 25,0µV (23,0 – 26,0), respectively. The median (IQR) aEEG upper and 
lower voltage ranges were significantly depressed to 21,5µV (20,0 – 26,5) and 12,0µV (12,0 
– 16,5) from 10min after the onset of 50% Xenon administration (p=0.002). After the initial 
Xenon induced depression in background aEEG voltage, no further aEEG changes were 
seen over the following 24h of ventilation with 50% xenon under fentanyl sedation. Mean 
arterial blood pressure and heart rate remained stable. 
Conclusion: Mean arterial blood pressure and heart rate were not significantly influenced by 
24h Xenon ventilation. 50% Xenon rapidly depresses background aEEG voltage to a steady 
~50% lower level in sedated healthy newborn pigs. Therefore, care must be taken when 
interpreting the background voltage in neonates also receiving Xenon.  
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Abbreviations 
aEEG     amplitude-integrated electroencephalography 
EEG     electroencephalography 
HT     therapeutic hypothermia 
i.v.     intravenous 
MAC     minimal alveolar concentration 
N2     nitrogen 
NMDA     N-methyl-D-aspartate  
O2      oxygen 
Trec     Rectal temperature  
Xe     Xenon 
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Introduction 
Monitoring the depth of sedation in newborns and children is of great interest, particularly as 
the use of sedatives and anaesthetics in this group of patients is increasing.[1] Most of the 
drugs that are frequently used in the paediatric population affect the characteristics of the 
electroencephalogram (EEG), and several calculated EEG parameters have been used to 
monitor the depth of anaesthesia in both children [2-4] and neonates.[5] The amplitude-
integrated EEG (aEEG) is a bedside monitoring tool widely used in newborns to continuously 
monitor brain activity and detect seizures.[6, 7] Following neonatal encephalopathy, the 
degree and timing of aEEG voltage depression and aEEG recovery also predicts outcome 
after perinatal asphyxia in both cooled and non-cooled newborns.[8, 9] However, the ability 
of the aEEG to predict outcome may be altered by any concurrent anaesthetic or sedative 
drug regimen that the patient is receiving. One example is the noble gas Xenon (Xe), which 
has both anaesthetic and analgesic actions.[10] We have previously shown that prolonged 
administration of 50% inhaled Xe to the developing brain is safe.[11, 12] Xenon also 
augments neuroprotection when combined with therapeutic hypothermia (HT) after hypoxia-
ischaemia in newborn animal studies.[13-15] Xenon significantly reduces EEG background 
voltage activity in healthy adults,[16] and reports using EEG parameters to assess depth of 
anaesthesia in adult patients inhaling Xe have been published.[17-20]  
However, the anaesthetic potency of Xe, or MAC-Xe (the minimal alveolar concentration of 
Xe preventing purposeful movement in 50% of subjects in response to a standardised painful 
stimulus), appears to be highly variable and age-dependent.[21] For instance, in eight 
healthy, newborn pigs, individual MAC-Xe ranged from 60 – 120%.[22] Though MAC-Xe for 
newborn humans has not been measured, its lower range is likely to be above 50%. This is 
because the MAC value for most inhalational anaesthetics is higher in newborn mammals 
compared to adults, and the MAC-Xe in adult humans was originally found to be 71%.[23]  
Although 50% Xe is a proven neuroprotective concentration experimentally when used in 
combination with therapeutic hypothermia (HT), 50% Xe alone does not provide adequate 
sedation to tolerate being ventilated while undergoing HT. Therefore, additional sedation 
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such as opioid administration is required. Importantly, the use of high doses of intravenous 
fentanyl, both with and without co-administration of 50% Xe, did not induce neuroapoptosis in 
the newborn pig brain, and is therefore likely to be safe also for humans.[11]  
We, as well as others, have previously shown that Xe administration reduces aEEG 
background voltage activity and suppresses seizures in asphyxiated cooled newborns.[12, 
24] Xenon, in combination with HT and infusion of opioids, is currently being investigated in 
clinical trials to reduce brain injury after neonatal encephalopathy.[12, 24, 25] Therefore, it is 
important to assess the effect of Xe on aEEG voltage changes, as this might change the 
ability of the aEEG to predict outcome during treatment in these patients. As the sedative 
effect of Xe cannot be assessed reliably in infants with concurrent encephalopathy, due to 
varying degrees of cerebral depression, the current study was carried out. 
This current study aimed to examine the effect of 50% inhaled Xe plus fentanyl infusion on 
background aEEG background activity, as well as cardiovascular parameters, in healthy 
newborn pigs.  
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Material and Methods 
Conduct of Experiment 
All experiments were conducted according to the United Kingdom Home Office license 
guidelines, and were approved by the University of Bristol Ethical Review Panel (Bristol, 
United Kingdom). This was a sub study of our original experiment, where we reported the 
safety of 50% Xe-ventilation in healthy newborn pigs, showing that ventilation with 50% Xe 
does not cause cellular injury in the newborn brain.[11] The current study uses data from five 
healthy newborn pigs (aged <24h) receiving intravenous fentanyl sedation, whilst being 
mechanically ventilated for 24h with 50% inhaled Xe, and maintained at normothermia (rectal 
temperature 38.5°C). 
 
Animals and Experimental groups  
Five crossbred landrace/large white pigs born at term (four male) with a median (range) age 
and weight of 10h (4 - 15h) and 1.7kg (1.2 - 1.9kg) were used. After a 1h baseline period on 
fentanyl sedation, all pigs received 24h of 50% inhaled Xe at normothermia. Intravenous 
fentanyl sedation was continued throughout. 
 
Animal Preparation, Baseline data and Management of pigs 
All animals were initially prepared as published in our original experiment.[11]. In brief, after 
initial intubation and insertion of umbilical arterial and venous catheters, continuous 
monitoring of mean arterial blood pressure and heart rate was enabled. During the 60min 
baseline period and the first 30min after Xe administration, mean arterial blood pressure and 
heart rate data were collected every 5min. For the following 23.5h of xenon administration, 
mean arterial blood pressure and heart rate data was collected every 30min, and the median 
was calculated for each pig hourly. 
Intensive care management of the animals followed standard procedures.[11] Pigs received 
intravenous maintenance fluid (5% dextrose/0.45% saline) at 10ml/kg/h. Tracheal suction 
was performed every 8h or as clinically indicated, and blood glucose, lactate, and pH values 
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were maintained between 3.0 and 8.0mmol/L, <3.5mmol/L, and pH 7.35 and 7.47 (analyzed 
at actual body temperature), respectively. Temperature measurements were undertaken with 
a rectal probe (reusable YSI 400 series, CritiCool, MTRE, Yavne, Israel) inserted 6cm into 
the rectum, and a skin probe (CritiCool, MTRE, Yavne, Israel) sited on the ear lobe. Both 
probes were calibrated before use within ±0.1°C, over a temperature range of 20 to 40°C, 
against a certified mercury-in-glass thermometer (BS593; Zeal, London, United Kingdom). 
Rectal temperature (Trec) was maintained at 38.5°C ± 0.2°C using a servo-controlled 
(CritiCool, MTRE, Yavne, Israel) body-wrap containing circulating water. Ventilation settings 
and inspired oxygen fraction were adjusted to maintain transcutaneous oxygen saturation 
between 95 and 98%, and the end-tidal carbon dioxide between 4.0 and 6.0kPa.  
 
Fentanyl Sedation and Xenon inhalation 
After animal preparation, the 60min baseline aEEG recording period was initiated. An i.v. 
fentanyl infusion of 1µg/kg/h was started with a bolus of 10µg/kg to ensure appropriate 
sedation during ventilation. The fentanyl infusion was adjusted to achieve the sedation 
required to ventilate a healthy newborn pig.  
After 60min of baseline measurements during ventilation, a xenon/oxygen/nitrogen mixture 
(Xe 50%/O2 30%/N2 20%) was delivered using an automated servo-controlled version of a 
previously described closed-circuit delivery system, for a period of 24h.[26] Target Xe 
concentration was achieved within 10min of onset, and was maintained at a concentration of 
50% throughout the whole 24h experiment. 
 
Amplitude-integrated EEG (aEEG) recording and analysis 
Cross brain single-channel aEEG and raw EEG (Olympic CFM 6000, Natus Medical 
Incorporated, Seattle, USA) was recorded from 3 subdermal needle electrodes (0.4mm 
(27G), Viasys Healthcare, Madison, USA) and stored digitally. Inter-electrode distance was 
3cm. The aEEG recording was started after animal preparation, and continued throughout 
the 60min baseline and 24h Xe-treatment periods during which all pigs received i.v. fentanyl 
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sedation. The recording was concluded after 24h of ventilation with 50%Xe and the animal 
was sacrificed.  
The aEEG background voltage changes were continuously recorded, and voltage criteria [27] 
were used to measure the voltage level of the upper and lower margin of the time-
compressed (6cm/hour) aEEG traces. For each semi-logarithmic aEEG trace the bandwidth 
representing the upper and lower voltage margin was read from the digital screen. The level 
for the upper band was 90% of the peak amplitude and the lower band was 10%. During the 
60min baseline period and the first 60min after Xe administration the bandwidth was read 
every 2min. The median of 30 baseline readings and 25 early xenon readings for each pig 
was calculated (excluding the 10min when xenon increased from 0 - 50%). These medians 
were compared. For the following 23h of xenon administration the last 10min period of each 
hour was read every 2min and the median of the 5 readings was calculated. 
 
Statistical Analysis 
Statistical analyses were performed with SPSS version 22 (SPSS Inc., Chicago, IL, USA). 
For both the upper and lower voltage margin separately, Wilcoxon signed rank test for paired 
samples were used comparing the 60min baseline period with the first 20min period after 
stable 50% xenon had been obtained. Mean arterial blood pressure and heart rate were 
continuously recorded and median values during baseline, Xe onset and Xe maintenance 
were compared visually. Two-sided testing with p <0.05 was considered statistically 
significant.   
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Results 
Physiological data 
Figure 1 presents the physiological parameters for each individual pig before Xe 
administration, during the onset of Xe and during the 24h Xe treatment period. Median 
(range) heart rate during baseline, Xe onset and Xe maintenance were 146/min (110 – 160), 
144/min (101 – 199) and 140/min (100 – 189), respectively. Median (range) arterial blood 
pressure during baseline, Xe onset and Xe maintenance were 54mmHg (40 –78), 69mmHg 
(47 – 84) and 54mmHg (40 – 79), respectively.  
Analyzing each pig’s individual response, we found that in 3 pigs (Pig 2, 4 and 5) there was a 
decrease in heart rate during the 24h Xe administration, whilst mean arterial blood pressure 
increased (Pig 2 and 4), or remained stable (Pig 5). 
Median (range) fentanyl dose was constant for each pig during the baseline period, 
(2microgram/kg/h; 0.9 – 2.5). However, increased fentanyl delivery was necessary after 
onset of xenon, increasing to a median of 2.5microgram/kg/h (2 – 7.5) during Xe onset and 
4.9microgram/kg/h (2.4 – 8.5) during Xe maintenance. Background aEEG voltage remained 
unchanged during the baseline period before Xe administration. 
 
aEEG changes with xenon 
Figure 2 shows an example of an individual (Pig 2) aEEG response to the onset of Xe 
followed by 24h of continuous ventilation with 50% Xe. For the 5 pigs, during the 1h baseline 
period, the median (IQR) upper aEEG voltage was 48,0µV (46,0 – 50,0). From 10min after 
the onset of 50% Xenon administration when the concentration had reached 50%, the 
median (IQR) aEEG upper voltage range was significantly depressed to 21,5µV (20,0 – 26,5) 
(p=0.002). The corresponding lower aEEG voltage during baseline was 25,0µV (23,0 – 26,0), 
reducing to 12,0µV (12,0 – 16,5) (p<0.002) with 50% Xe. Figure 3 shows the median 
(interquartile range) upper and lower voltage margin during the whole treatment period. 
During steady Xe ventilation the upper and lower voltage level (aEEG bandwidth) did not 
significantly change.  
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Discussion 
This study shows that background aEEG voltage in sedated healthy newborn pigs is rapidly 
reduced upon administration of 50% inhaled Xe, and remains suppressed at the same level 
throughout prolonged Xe delivery. This is consistent with clinical findings in encephalopathic 
newborns.[12, 24] As these sedated healthy pigs did not receive an hypoxic insult, this 
suggests a direct pharmacological effect of Xe. Additionally, prolonged Xe delivery did not 
significantly alter cardiovascular parameters.  
In pediatric anaesthesia, volatile anaesthetics are commonly used, as they have a 
predictable onset and offset of action, and are assumed to be safe. Importantly, an adequate 
anaesthetic depth can be achieved, and rapidly tailored to clinical need, while in most cases 
maintaining hemodynamic stability.[28] However, there is evidence that inhalational 
anaesthetics might be associated with increased apoptosis in the developing brain,[29-31] 
which is a cause for concern. Xenon, a non-competitive inhibitor of the N-methyl-D-aspartate 
(NMDA) receptor, has been shown to double neuroprotection when combined with 
therapeutic hypothermia following hypoxic-ischaemic brain injury in multiple preclinical 
models.[13-15] This has led to two clinical trials using Xe as an additional neuroprotective 
agent during cooling in newborns suffering neonatal encephalopathy of hypoxic-ischaemic 
origin; TOBY-Xe and CoolXenon.[12, 25] One of the two trials (TOBY-Xe) has been 
completed, which showed no additional short-term neuroprotection when combining cooling 
with 30% inhaled Xe (starting 10h after birth), compared to cooling only as the standard 
treatment.[25] There are two important differences between the two study protocols; 
CoolXenon aims to start Xe administration earlier (within 5h of birth), and uses a higher 
concentration of inhaled Xe (50%). Data from the CoolXenon trial are therefore eagerly 
awaited. However, recruitment is estimated to end in December 2016, followed by 18 months 
of follow-up. 
Amplitude-integrated EEG is widely used in neonatal units and is an established method for 
prognosticating outcome in both normothermic and cooled asphyxiated newborns.[8, 9] 
However, in order to accurately interpret aEEG monitoring during clinical Xe administration, 
 11 
the effects of Xe on the neonatal aEEG must be investigated. As the sedative effect of Xe 
cannot be assessed reliably in infants with concurrent encephalopathy, due to varying 
degrees of cerebral depression, the current study was carried out. The proven 
neuroprotective Xe dose for newborn animals (50%) is considered to be a sub-anaesthetic 
dose, as it is below the MAC-Xe of healthy newborn pigs (previously found to be 60 – 
120%).[22, 31] We show that 50% Xe significantly reduces aEEG background voltage activity 
by around 50% in sedated healthy newborn pigs. The reduction was small for one pig (pig 5) 
and significant for the remaining four. Since MAC-Xe varies over a large range (60 - 120%), 
one could expect 50% xenon to exert a variable depression on the aEEG. We have 
previously shown that there is large inter-individual variation in MAC values for Xe in healthy 
newborn pigs.[22] Importantly, MAC-Xe and aEEG changes were correlated, as pigs with low 
MAC-Xe levels had greater aEEG depression at 50% Xe.  
Xenon has also been intensively studied by several groups with regards to safety and 
hemodynamic stability in neonatal models.[11, 15, 31, 32] Xenon has a rapid onset and 
offset of action regardless of duration of administration, as it does not accumulate within the 
body.[18] As with most inhalational anaesthetics, Xe reduces EEG background voltage level 
in healthy adults[16], and monitoring has been developed using bispectral analysis of EEG 
traces to monitor depth of anaesthesia.[17-20]  
In the clinical setting of neonatal encephalopathy, Azzopardi et al. have shown that Xe 
reduces seizure activity, with seizures reoccurring when Xe was stopped.[24] In our clinical 
feasibility study, using Xe as an add-on treatment during therapeutic hypothermia in 
asphyxiated newborns, we found that Xe depressed aEEG background voltage activity in 
some newborns.[12] Of interest, here we show that after a significant reduction in aEEG 
voltage in piglets after the onset of Xe, no further changes were seen on the aEEG trace 
throughout the remaining treatment period. This suggests that there is no adaptation or 
tolerance to Xe treatment over a therapeutic time window. As Xe is thought to be non-toxic to 
the neonatal brain, an anaesthetic such as Xe that can be administered for long periods of 
time without needing to increase the dose is of great potential use clinically. There is also 
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potential benefit for the injured newborn brain, as an anaesthesia-induced reduction in brain 
activity might positively alter the clearance of metabolic waste in the central nervous 
system.[34] 
As shown in Figure 1, fentanyl doses had to be increased over time during the 24-hour 
experiment. The increased need of fentanyl during continuous intravenous administration 
has been described in neonates before and might be associated with the uniform 
development of opioid tolerance.[35] Interestingly, we have previously demonstrated that Xe 
reduces the need for inotropic support in newborn pigs,[32] and despite a high level of 
fentanyl administration in all pigs in the current study, there was no need for inotropic 
support. In three of the five pigs (Pig 2, 4 and 5) heart rate decreased over time, whilst mean 
arterial blood pressure increased (Pig 2 and Pig 4) or maintained stable (Pig 5). In theory, 
this might be due to a waning sedative effect of Xe during 24h administration. However, we 
believe that in pig 5 this was due to high fentanyl levels, whereas in pig 2 and 4, 
cardiovascular stability increased.  
There are some limitations to our study. Firstly, the total number of animals is low. However, 
as the effect of aEEG voltage change after Xe administration was immediate and significant, 
it is unlikely that further experiments would have added any additional information. Secondly, 
we cannot prove that fentanyl alone administered over a 24h treatment period will not alter 
aEEG background voltage activity, though after 60min of baseline fentanyl only sedation, 
aEEG did not change in any of the pigs. However, opioids may also influence the aEEG 
voltage.[36] Measuring fentanyl blood levels at certain time points might give further insight 
into the cumulative dosages each individual pig received, however we were not able to 
analyze blood levels in this current study. Thirdly, the aEEG was analyzed at specific time 
points rather than using a continuous spectral analysis. Though analysis of the continuous 
effect of Xe has potential benefits, using exact time points allowed us to identify a specific 
temporal effect of Xe on the aEEG background voltage, and later time points showed no 
further changes after this initial suppression of the aEEG by Xe. 
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In summary, as Xe depresses background aEEG voltage, care must be taken when using 
the aEEG to predict the outcome of newborns receiving Xe as an additive neuroprotective 
therapy after neonatal encephalopathy. 
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Figures 
 
 
Figure 1: Physiological data for the 5 individual pigs during each individual treatment. Median 
data is presented for heart rate (HR), mean arterial blood pressure (MABP), xenon 
concentration (Xe) and fentanyl dosage. The x-axis is non-continuous (grey shaded area), 
presenting 5min data during the 60min baseline and first 30min after Xe onset, followed by 
hourly data during the 24h Xe maintenance period.  
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Figure 2: Example of an individual response to the onset of Xe from one aEEG trace 
recorded during the 24h of Xe ventilation (pig number 2). The Y-axis shows the semi-
logarithmic voltage (μV) scale and the x-axis shows time frames (each small grey box 
indicating a 10min period).  
 
 
Figure 3: Median (interquartile range) upper and lower voltage margin for all five pigs. The x-
axis represents data analysed every 2min during baseline period and during the first hour of 
Xe onset. Thereafter (grey shaded area), for the following 23h of xenon administration the 
last 10min period of each hour was analysed every 2min to best represent the voltage 
margins during Xe maintenance. The y-axis shows the semi-logarithmic voltage (μV) scale. 
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